Abstract
Background
Recurrent hemorrhage with secondary glaucoma is a rare but serious complication following proton beam irradiation (PBI) of iris melanoma. We report a case in which photodynamic therapy (PDT) was successfully used to treat this complication.
Methods
The history, clinical features and management of a patient with iris melanoma who was treated with PBI and later developed recurrent hyphema and increased intraocular pressure are presented. PDT was used to treat the abnormal intralesional blood vessels which caused the recurrent intraocular haemorrhage.
Results
The intralesional blood vessels regressed following PDT. The patient did not experience any further episodes of hyphema or elevated intraocular pressure.
Conclusions
Our case demonstrates that the vascular abnormalities following irradiation of iris melanoma may respond favorably to PDT in selected cases. To our knowledge, this is the first reported case in which PDT was used to treat recurrent hyphema caused by abnormal intralesional blood vessels after proton beam irradiation of iris melanoma.
Similar content being viewed by others
References
Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD (2005) Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 63:109–115
Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piquet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 117:1177–1187
Porrini G, Giovannini A, Amato G, Ioni A, Pantanetti M (2003) Photodynamic therapy of circumscribed choroidal hemangioma. Ophthalmology 110:674–680
Schmidt-Erfurth U, Hasan T, Flotte T, Gragoudas E, Birngruber R (1994) Photodynamic therapy of experimental, intraocular tumors with benzoporphyrin-lipoprotein. Ophthalmologe 91:348–356
Davidorf J, Davidorf F (1992) Treatment of iris melanoma with photodynamic therapy. Ophthalmic Surg 23:522–527
Husain D, Miller JW, Kenney AG, Michaud N, Flotte TJ, Gragoudas ES (1997) Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology 104:1242–1250
Muller VA, Ruokonen P, Schellenbeck M, Hartmann C, Tetz M (2003) Treatment of rubeosis iridis with photodynamic therapy with verteporfin—A new therapeutic and prophylactic option for patients with the risk of neovascular glaucoma? Ophthalmic Res 35:60–64
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have full control of all primary data, and agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data upon request.
Rights and permissions
About this article
Cite this article
Trichopoulos, N., Damato, B. Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma. Graefes Arch Clin Exp Ophthalmol 245, 1573–1575 (2007). https://doi.org/10.1007/s00417-007-0584-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0584-7